Filana Therapeutics (FLNA) Total Assets by Year
Filana Therapeutics, Inc. closed fiscal year 2025 with $118.4M in total assets, $44.0M in total liabilities and $74.4M in shareholder equity. Total assets fell 24.9% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Filana Therapeutics, Inc. has filed alongside them.
Ticker history: SAVA became FLNA (Filana Therapeutics, Inc.) on . Earlier news and filings retain their original names and dates. View SAVA history.
Annual figures, oldest first. Point at a bar to read its period.
FLNA Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25Filing | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing | FY18Filing | FY17Filing | FY16Filing | FY15Filing | FY14Filing | FY13Filing | FY12Filing | FY11Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $118.4M-24.9% | $157.5M+3.9% | $151.7M-35.4% | $234.8M-12.0% | $266.8M+182.9% | $94.3M+301.5% | $23.5M+16.6% | $20.1M+85.9% | $10.8M-43.9% | $19.3M-39.5% | $31.9M-22.0% | $40.9M-18.4% | $50.1M-11.9% | $56.9M-42.5% | $99.0M |
| Total Liabilities | $44.0M+271.6% | $11.8M-16.7% | $14.2M+94.6% | $7.3M-43.3% | $12.9M+512.7% | $2.1M+51.4% | $1.4M+171.4% | $511K-54.9% | $1.1M+70.2% | $665K-73.9% | $2.6M+200.1% | $850K-52.8% | $1.8M-95.9% | $43.7M-19.9% | $54.6M |
| Total Equity | $74.4M-48.9% | $145.7M+6.0% | $137.5M-39.6% | $227.5M-10.4% | $253.9M+175.4% | $92.2M+317.2% | $22.1M+12.6% | $19.6M+102.4% | $9.7M-48.0% | $18.6M-36.5% | $29.4M-26.7% | $40.1M-17.1% | $48.3M+267.7% | $13.1M-70.4% | $44.4M |
FLNA Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'25Filing | Q2'25Filing | Q1'2510-Q | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing | Q3'23Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $103.9M-23.3% | $108.4M-23.1% | $118.4M-24.9% | $129.7M-42.0% | $135.4M-44.4% | $140.9M-9.5% | $157.5M+3.9% | $223.8M+29.7% | $243.6M+23.5% | $155.7M-28.6% | $151.7M-35.4% | $172.5M-16.8% |
| Total Liabilities | $40.3M-15.0% | $40.2M+202.1% | $44.0M+271.6% | $48.2M-15.7% | $47.4M-13.2% | $13.3M-82.7% | $11.8M-16.7% | $57.1M+228.0% | $54.6M+205.1% | $77.1M+446.7% | $14.2M+94.6% | $17.4M+103.3% |
| Total Equity | $63.6M-27.7% | $68.1M-46.6% | $74.4M-48.9% | $81.6M-51.1% | $88.0M-53.4% | $127.6M+62.4% | $145.7M+6.0% | $166.6M+7.4% | $189.0M+5.4% | $78.6M-61.5% | $137.5M-39.6% | $155.1M-21.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Filana Therapeutics, Inc. financials
Frequently Asked Questions
Filana Therapeutics, Inc. closed fiscal year 2025 with $118.4M in total assets, $44.0M in total liabilities and $74.4M in shareholder equity.
Filana Therapeutics, Inc. (FLNA) total assets fell by 24.9% year over year, from $157.5M to $118.4M in fiscal year 2025.
Across the 15 fiscal years this page covers, Filana Therapeutics, Inc. (FLNA) total assets went from $99.0M in fiscal year 2011 to $118.4M in fiscal year 2025.
Filana Therapeutics, Inc. (FLNA) reported $103.9M in total assets in Q2 2026. This represents a decrease of 23.3% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Filana Therapeutics, Inc. (FLNA) reported on that line in every period on record.